Designer natriuretic peptides: a vision for the future of heart failure therapeutics (Q37911516)

25 August 2017

1 reference

title

Designer natriuretic peptides: a vision for the future of heart failure therapeutics (English)

1 reference

25 August 2017

0 references

Rosita Zakeri

1

1 reference

PubMed ID

21815778

25 August 2017

John C Burnett

series ordinal

2

1 reference

25 August 2017

4 August 2011

1 reference

Canadian Journal of Physiology and Pharmacology

25 August 2017

1 reference

25 August 2017

89

1 reference

25 August 2017

8

1 reference

25 August 2017

593-601

1 reference

Vasopressin-dependent inhibition of the C-type natriuretic peptide receptor, NPR-B/GC-B, requires elevated intracellular calcium concentrations

25 August 2017

1 reference

In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE).

21 January 2018

1 reference

Differential regulation of natriuretic peptide receptor messenger RNAs during the development of cardiac hypertrophy in the rat.

21 January 2018

1 reference

Low dose nesiritide and the preservation of renal function in patients with renal dysfunction undergoing cardiopulmonary-bypass surgery: a double-blind placebo-controlled pilot study.

21 January 2018

1 reference

Local renal delivery of a natriuretic peptide a renal-enhancing strategy for B-type natriuretic peptide in overt experimental heart failure

21 January 2018

1 reference

Low-dose nesiritide in human anterior myocardial infarction suppresses aldosterone and preserves ventricular function and structure: a proof of concept study

21 January 2018

1 reference

Atrial natriuretic factor in normal subjects and heart failure patients. Plasma levels and renal, hormonal, and hemodynamic responses to peptide infusion

21 January 2018

1 reference

Novel bifunctional natriuretic peptides as potential therapeutics.

21 January 2018

1 reference

Natriuretic peptide receptor-B in adult rat ventricle is predominantly confined to the nonmyocyte population

21 January 2018

1 reference

Simultaneous assessment of unprocessed ProBNP1-108 in addition to processed BNP32 improves identification of high-risk ambulatory patients with heart failure

21 January 2018

1 reference

Normalization of the calcineurin pathway underlies the regression of hypertensive hypertrophy induced by Na+/H+ exchanger-1 (NHE-1) inhibition.

21 January 2018

1 reference

Hemodynamic and renal effects of atrial natriuretic peptide in congestive heart failure

21 January 2018

1 reference

Quantitative mass spectral evidence for the absence of circulating brain natriuretic peptide (BNP-32) in severe human heart failure

21 January 2018

1 reference

Immunoreactivity and guanosine 3',5'-cyclic monophosphate activating actions of various molecular forms of human B-type natriuretic peptide.

21 January 2018

1 reference

Gene Expression, Secretion, and Autocrine Action of C-Type Natriuretic Peptide in Cultured Adult Rat Cardiac Fibroblasts

21 January 2018

1 reference

Four functionally distinct C-type natriuretic peptides found in fish reveal evolutionary history of the natriuretic peptide system.

21 January 2018

1 reference

The role of NHE-1 in myocardial hypertrophy and remodelling

21 January 2018

1 reference

Effect of atrial natriuretic peptide on left ventricular remodelling in patients with acute myocardial infarction

21 January 2018

1 reference

A novel chimeric natriuretic peptide reduces cardiomyocyte hypertrophy through the NHE-1-calcineurin pathway

21 January 2018

1 reference

Pharmacodynamics of a novel designer natriuretic peptide, CD-NP, in a first-in-human clinical trial in healthy subjects

21 January 2018

1 reference

Evidence for functional heterogeneity of circulating B-type natriuretic peptide.

21 January 2018

1 reference

Design, synthesis, and actions of a novel chimeric natriuretic peptide: CD-NP.

21 January 2018

1 reference

Recent advances in cardiopulmonary resuscitation: cardiocerebral resuscitation

21 January 2018

1 reference

Detection of endogenous B-type natriuretic peptide at very low concentrations in patients with heart failure

21 January 2018

1 reference

Natriuretic peptides, their receptors, and cyclic guanosine monophosphate-dependent signaling functions

21 January 2018

1 reference

Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial.

21 January 2018

1 reference

Nonhypotensive low-dose nesiritide has differential renal effects compared with standard-dose nesiritide in patients with acute decompensated heart failure and renal dysfunction.

21 January 2018

1 reference

Short-term risk of death after treatment with nesiritide for decompensated heart failure: a pooled analysis of randomized controlled trials

21 January 2018

1 reference

Risk of worsening renal function with nesiritide in patients with acutely decompensated heart failure

21 January 2018

1 reference

Inhibitory effect of C-type natriuretic peptide (CNP) on cultured cardiac myocyte hypertrophy: interference between CNP and endothelin-1 signaling pathways

21 January 2018

1 reference

Cardiomyocyte-restricted over-expression of C-type natriuretic peptide prevents cardiac hypertrophy induced by myocardial infarction in mice.

21 January 2018

1 reference

Antihypertensive and hypotensive effects of atrial natriuretic factor in men.

21 January 2018

1 reference

Biochemistry of natriuretic peptides

21 January 2018

1 reference

Generalizability and longitudinal outcomes of a national heart failure clinical registry: Comparison of Acute Decompensated Heart Failure National Registry (ADHERE) and non-ADHERE Medicare beneficiaries

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1139/Y11-048

1 reference

25 August 2017

1 reference

PubMed ID

21815778